Wu Ting printed out the first draft of his paper.
"Directors, this is the first draft of my paper: 'A Clinical Study on the Fatal Toxic Side Effects of Pfizer's New Drug Sorafenib and a Discussion on the Authority of FDA Certification'."
Wu Ting gestured to Zhang Heng and Jia Jun. "You two, hand over the lab, clinical, and statistical data to the experts for review."
"Right away."
Zhang Heng was young and accomplished. As a graduate of Union, he had seen his share of major events, but he had never experienced a lineup like today's, much less a meeting where his team was the absolute center of attention.
He couldn't help but feel a surge of excitement and bliss.
Zhang Heng had once harbored thoughts of competing with Wu Ting, but at this moment, he felt just how great it was to ride Wu Ting's coattails.
Once this paper was published, Zhang Heng could see a clear path to qualifying for a promotion to chief physician.
